Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium channels (NaV1.1–NaV1.9) are a family of transmembrane proteins essential for the initiation and propagation of action potentials in excitable cells, including neurons, cardiomyocytes, and skeletal muscle fibers [14, 17]. These channels open in response to membrane depolarization, allowing the rapid influx of sodium ions into the cell [21]. The family consists of nine alpha-subunits (NaV1.1 to NaV1.9), each with distinct tissue distributions and physiological roles [3, 14]. For instance, NaV1.1, NaV1.2, and NaV1.6 are primarily found in the central nervous system, while NaV1.7, NaV1.8, and NaV1.9 are localized in the peripheral nervous system [16, 23]. Mutations in the genes encoding these channels are linked to a wide range of "channelopathies," such as epilepsy, chronic pain syndromes, and cardiac arrhythmias [17, 21]. Pharmacologically, these channels are the primary targets for local anesthetics, antiarrhythmics, and anticonvulsants [4, 12]. Most of these drugs work by blocking the pore or stabilizing the inactivated state of the channel to reduce hyperexcitability [4, 12]. Modern drug discovery focuses on developing subtype-selective inhibitors to minimize systemic side effects, particularly for treating pain and epilepsy [7, 9]. These channels are also the targets of various natural toxins, which have been instrumental in studying their structure and function [15, 17].
Sodium channel blocker; stabilization of the inactivated state of the channel.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated sodium channel (NaV1.1–NaV1.9) (NaV1.1–NaV1.9).